Trials / Completed
CompletedNCT01518244
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to assess the efficacy and tolerability of changing to AZARGA® from prior COMBIGAN® pharmacotherapy in participants with open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brinzolamide/timolol maleate fixed combination |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2012-01-25
- Last updated
- 2015-08-07
- Results posted
- 2014-04-04
Source: ClinicalTrials.gov record NCT01518244. Inclusion in this directory is not an endorsement.